Öğr. Gör. Dr. NAMİ YEYİN

Yayın Ağı

Makaleler 59

1. Effect of previous (177)Lu-DOTATATE treatment on (90)Y-microsphere treatment response in neuroendocrine tumor patients with liver metastasis.

Aghazada F., Uslu-Besli L., KİBAR A., ŞAHİN O. E., YEYİN N., Ertek E., et al.

Annals of nuclear medicine , cilt.40, sa.1, ss.41-49, 2026 (SCI-Expanded, Scopus)

2. A multicenter quantitative evaluation of Organ-specific radiation doses in head and neck CT: A dosimetric assessment using the Alderson Rando phantom.

Kesmezacar F. F., Günay O., Tunçman Kayaokay D., Yeyin N., Demirci A., Karaçam S., et al.

RADIATION AND ENVIRONMENTAL BIOPHYSICS , cilt.1, ss.1-11, 2025 (SCI-Expanded, Scopus)

3. Inspection of lead aprons damage and evaluation of transmission rate with a 99mTc point-source

İpek Işıkcı N., Abuqbeitah M., YEYİN N., Akyol S., DEMİR M.

Nuclear Engineering and Technology , cilt.57, sa.10, 2025 (SCI-Expanded, Scopus)

4. Investigation of the Partial Volume Effect in Pre-Dosimetry of Liver Tumors for 90Y Radioembolization: A Phantom Study

Akar A. D., YEYİN N., Akyoj S., Demir Ö., Coker E. G., Demir M.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.34, sa.3, ss.180-187, 2025 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

5. Radiation dose variability in critical thoracic organs during CT imaging: A multi-centre phantom dosimetry study

Kesmezacar F. F., Tunçman Kayaokay D., Günay O., Yeyin N., Demirci A., Karaçam S., et al.

RADIATION PHYSICS AND CHEMISTRY , sa.238, ss.1-9, 2025 (SCI-Expanded, Scopus)

6. Evaluating organ-specific radiation exposure in transcatheter arterial chemoembolization (TACE): A phantom-based assessment of safety thresholds for interventional radiology applications

Tunçman Kayaokay D., Özgür E., Kesmezacar F. F., Yeyin N., Karaçam S., Günay O., et al.

RADIATION PHYSICS AND CHEMISTRY , cilt.238, ss.1-7, 2025 (SCI-Expanded, Scopus)

7. Head and Neck Imaging with a Dental CBCT Device: Comparison of 360° and 180° Rotation Angles in Effective Dose and Quantitative Image Quality in a Phantom Study.

Amasya H., Günay O., Kesmezacar F. F., Tunçman Kayaokay D., Yeyin N., Kekeç E., et al.

CURRENT MEDICAL IMAGING REVIEWS , cilt.21, ss.1-13, 2025 (SCI-Expanded, Scopus)

8. Remnant Tissue Dosimetry in Well-differentiated Thyroid Cancer İyi Diferansiye Tiroit Kanserinde Bakiye Doku Dozimetrisi

YEYİN N.

Nuclear Medicine Seminars , cilt.11, sa.1, ss.6-10, 2025 (Scopus)

9. Comprehensive organ-specific radiation dose mapping in coronary angiography using the Alderson Rando phantom: An experimental approach to optimize patient safety

Tunçman Kayaokay D., Kesmezacar F. F., Yeyin N., Karaçam S., Günay O., Karabağ T., et al.

RADIATION PHYSICS AND CHEMISTRY , cilt.233, ss.1-9, 2025 (SCI-Expanded, Scopus)

10. Lu-177 Labeled Somatostatin Receptors and PSMA Dosimetry Lu-177 İşaretli Somatostatin Reseptörleri ve PSMA Dozimetrisi

Toklu T., Kozanlılar B., YEYİN N., Hacıosmanoğlu T., DEMİR M., USTA S.

Nuclear Medicine Seminars , cilt.11, sa.1, ss.28-38, 2025 (Scopus)

11. Comparison of Thyroid Uptake Values Measured from 131I Scintigraphy and Uptake Probe in Hyperthyroid Patients.

YEYİN N., Akyol S., Uslu-Beşli L., DEMİR M.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre , cilt.34, sa.1, ss.48-56, 2024 (SCI-Expanded, Scopus)

12. In-depth exploration of the radiation exposure to staff performing endoscopic retrograde cholangiopancreatography procedures (ERCP) through RANDO phantom and TLDs

Kesmezacar F. F., Tunçman D., Nayci A. E., Günay O., Yeyin N., Üzüm G., et al.

JAPANESE JOURNAL OF RADIOLOGY , cilt.42, sa.9, ss.1058-1066, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. US-guided percutaneous ablation of thyroid nodules with177LU-MAA (LUTMA)- Feasibility study

Sager S., Akgun E., Abuqbeitah M., Nazari A., YEYİN N., KARAYEL E., et al.

REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR , cilt.43, sa.4, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. Evaluation of Radiation Exposure of the Oral Cavity in C-Arm Fluoroscopy: A Dose Analysis

Tunçman D., Yazıcı S. D., Günay O., Kesmezacar F. F., Yeyin N., Aksoy S., et al.

International Journal of Computational and Experimental Science and Engineering (IJCESEN) , cilt.10, sa.2, ss.181-188, 2024 (TRDizin)

15. Determining the Radiation Dose Levels the Kidney is Exposed to in Kidney Stone Fragmentation Procedures

Şengül A., Günay O., Tunçman D., Kekeç E., Zengin T., Kesmezacar F. F., et al.

International Journal of Computational and Experimental Science and ENgineering , cilt.10, sa.1, ss.79-84, 2024 (Hakemli Dergi)

16. Determination of Radiation Dose Level Exposed to Thyroid in C-Arm Scopy

Özlen M. S., Cuma A. B., Yazıcı S. D., Yeyin N., Demir Ö., Aksoy H., et al.

International journal of applied sciences and radiation research , ss.21-31, 2024 (Hakemli Dergi)

17. Determining the Radiation Dose Levels the Kidney is Exposed to in Kidney Stone Fragmentation Procedures

ŞENGÜL A., GÜNAY O., Kekeç E., Zengin T., TUNÇMAN D., KESMEZACAR F. F., et al.

International Journal of Computational and Experimental Science and Engineering , cilt.10, sa.1, ss.79-84, 2024 (Scopus, TRDizin)

18. Hepatopulmonary Shunt Ratio Verification Model for Transarterial Radioembolization

Yeyin N., Kesmezacar F. F., Tunçman D., Demir Ö., Uslu-Beşli L., Günay O., et al.

CURRENT RADIOPHARMACEUTICALS , cilt.17, sa.3, ss.276-284, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Thermoluminescence Dosimeters Holder Cassette Design and 3D Printing

TUNÇMAN D., KESMEZACAR F. F., GÜNAY O., YEYİN N., DEMİR Ö., DEMİR M., et al.

International Journal of Computational and Experimental Science and Engineering , cilt.9, sa.4, ss.320-324, 2023 (Scopus, TRDizin)

20. A multi-institutional assessment of eye lens dose in nuclear medicine clinics

Abuqbeitah M., DEMİR M., Işikci N. I., Kozanlilar B., Kovan B., YEYİN N., et al.

Nuclear Medicine Communications , cilt.44, sa.9, ss.772-776, 2023 (SCI-Expanded, Scopus)

21. EĞİTİM VE ARAŞTIRMA AMAÇLI 3B BASKILI KARACİĞER FANTOM TASARIMI

Kesmezacar f. f., Yeyin N., demir ö.

International Journal of 3D Printing Technologies and Digital Industry , cilt.7, sa.2, ss.175-183, 2023 (TRDizin)

22. 3 Boyutlu Baskı Teknolojisi Kullanılarak Anatomik Akciğer Araştırma ve Eğitim Fantomu Tasarım ve Üretimi

Kesmazacar F. F., Tunçman D., Yeyin N.

İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi (IGUSABDER) , cilt.20, sa.20, ss.1-11, 2023 (TRDizin)

23. Dose Calibrator Measurements in the Case of Voltage Fluctuations

günay o., Altıntaş İ. N., Demir M., Yeyin N.

International Journal of Computational and Experimental Science and Engineering , cilt.9, sa.2, ss.161-164, 2023 (Scopus, TRDizin)

24. Selective Intra-Arterial Lutetium-177-Labeled Prostate-Specific Membrane Antigen Therapy for Castration-Resistant Prostate Cancer: Initial Results.

Sayman H. B., Gulsen F., Sager S., Akgun E., Yeyin N., Bilgic S., et al.

Journal of vascular and interventional radiology : JVIR , cilt.33, ss.342-345, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. Author's Reply: Re: Comparison of Anticoagulation Regimens Following Stent Placement for Nonthrombotic Lower Extremity Venous Disease

SAYMAN H. B., GÜLŞEN F., Sager S., AKGÜN E., YEYİN N., BİLGİÇ S., et al.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY , cilt.33, sa.3, ss.342, 2022 (SCI-Expanded, Scopus)

26. Small Molecule, Multimodal, [F-18]-PET and Fluorescence Imaging Agent Targeting Prostate-Specific Membrane Antigen: First-in-Human Study

Aras O., DEMİRDAĞ Ç., Kommidi H., Guo H., Pavlova I., AYGÜN A., et al.

CLINICAL GENITOURINARY CANCER , cilt.19, sa.5, ss.405-416, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. Ra-223 Tedavisinde Dozimetri

DEMİR M., YEYİN N.

TURKIYE KLINIKLERI JOURNAL OF MEDICAL SCIENCES , cilt.1, sa.1, ss.30-34, 2021 (Scopus, TRDizin)

28. Radyasyon Güvenliği Kılavuzu: Genel Tanımlar ve Nükleer Tıp Uygulamalarında Radyasyondan Korunma Kuralları

Parlak Y., Uysal B., Kıraç F. S., Kovan B., Demir M., Ayan A., et al.

Nükleer Tıp Seminerleri , sa.6, ss.71-89, 2020 (Hakemli Dergi) Sürdürülebilir Kalkınma

29. The impact of different computational assumptions in(131)I dosimetry for hyperthyroidism therapy

Abuqbeitah M., Sager S., DEMİR M., YEYİN N., AKOVALI B., SÖNMEZOĞLU K.

MEDICAL PHYSICS , cilt.47, sa.11, ss.5810-5816, 2020 (SCI-Expanded, Scopus)

30. Acceptance Tests and Quality Control of the Positron Emission Tomography (PET) Systems

Hacıosmanoğlu T., DEMİR M., Toklu T., Kıraç F. S., İnce M., Parlak Y., et al.

NUCLEAR MEDICINE SEMINARS , cilt.6, sa.2, ss.51-70, 2020 (Scopus)

31. Thyroid uptake test with portable device (COTI) after ¹³¹I tracer administration: proof of concept.

Abuqbeitah M., Demir M., Yeyin N., Sager S., Gray D.

Radiation and environmental biophysics , cilt.59, ss.553-558, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

32. Radyonüklid Tedavide KullanılanRadyofarmasötiklerin Fiziksel Özellikleri veRadyasyon Korunması

YEYİN N., DEMİR M., Abuqbeitah M.

Türkiye Klinikleri Sağlık Bilimleri Dergisi , 2019 (TRDizin)

33. Comparison between planar, SPECT and SPECT/computed tomography systems in 99mTc- nanocolloid sentinel lymph node imaging: phantom design and clinical investigations. Erratum.

IŞIKCI N., ABUQBEITAH M., GUNAY O., Yeyin N., USLU-BESLI L., SAGER S., et al.

Nuclear medicine communications , cilt.40, ss.973, 2019 (SCI-Expanded, Scopus)

34. Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma

Sager S., Akgun E., USLU-BESLI L., Asa S., Akovali B., SAHIN O., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.40, sa.5, ss.461-468, 2019 (SCI-Expanded, Scopus)

35. Lesion detection in conventional gamma camera, SPECT and SPECT / CT systems: Phantom study

Ulusoy Y., Karagöz M., YEYİN N., DEMİR M.

e-Cumhuriyet Tıp Dergisi (elektronik) , cilt.41, sa.1, ss.75-81, 2019 (SCI-Expanded, Scopus, TRDizin)

36. ESTIMATION OF THE ORGAN ABSORBED DOSES AND EFFECTIVE DOSE FROM Ga-68-PSMA-11 PET SCAN

Demirci E., Toklu T., Yeyin N., Ocak M., ALAN SELÇUK N., Araman A., et al.

RADIATION PROTECTION DOSIMETRY , cilt.182, sa.4, ss.518-524, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

37. Red bone marrow dose estimation using several internal dosimetry models for prospective dosimetry-oriented radioiodine therapy

Abuqbeitah M., Demir M., Cavdar I., Tanyildizi H., Yeyin N., Uslu-Besli L., et al.

RADIATION AND ENVIRONMENTAL BIOPHYSICS , cilt.57, sa.4, ss.395-404, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

38. Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer

Abuqbeitah M., Demir M., Kabasakal L., Cavdar I., Uslu-Besli L., Yeyin N., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.39, sa.11, ss.969-975, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

39. Calculation of Embryo/Fetus Dose in Pregnant Thyroid Patients Who Have Accidentally Received Radioiodine

DEMİR M., ÇAVDAR İ., YEYİN N., Abuqubetah M., USLU BEŞLİ R. L., İpek N., et al.

Okmeydanı Tıp Dergisi , cilt.1, ss.1-4, 2018 (SCI-Expanded, Scopus, TRDizin)

40. Blood clearance and occupational exposure for Lu-177-DOTATATE compared to Lu-177-PSMA radionuclide therapy

Abuqbeitah M., Demir M., Uslu-Besli L., Yeyin N., Sonmezoglu K.

RADIATION AND ENVIRONMENTAL BIOPHYSICS , cilt.57, sa.1, ss.55-61, 2018 (SCI-Expanded, Scopus)

41. Evaluation of PET Scanner Performance in PET/MR and PET/CT Systems: NEMA Tests

Demir M., Toklu T., Abuqbeitah M., CETIN H., SEZGIN H. S., Yeyin N., et al.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.27, sa.1, ss.10-18, 2018 (ESCI, Scopus, TRDizin)

42. Value of personalised radiation absorbed dose calculations for the radioiodine ablation therapy in patients with low-risk well differentiated thyroid cancer

Yeyin N., Selcuk N. A., Demirci E., Toklu T., Akyel R., Sahin O. E., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.44, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and Dosimetry

Kabasakal L., Toklu T., Yeyin N., Demirci E., Abuqbeitah M., Ocak M., et al.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.26, sa.2, ss.62-68, 2017 (ESCI, Scopus, TRDizin)

44. RADYONÜKLİD TEDAVİLERDE DOZ HIZI ÖLÇÜMLERİ VE HASTA TABURCU EDİLME KOŞULLARININ DEĞERLENDİRİLMESİ

YEYİN N., Abuqubetah M., ÇAVDAR İ., SÖNMEZOĞLU K., DEMİR M.

İstanbul Tıp Dergisi , cilt.80, ss.1-6, 2017 (SCI-Expanded, Scopus, TRDizin)

45. THE EVALUATION OF DOSE RATE MEASUREMENTS AND DISCHARGE TIME AFTER RADIONUCLIDE THERAPY

YEYİN N., AKYEL R., Abuqbeitah M., Cavdar I., SÖNMEZOĞLU K., DEMİR M.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.80, sa.1, ss.1-6, 2017 (ESCI, TRDizin)

46. Comparison Between PET/MR and PET/CT: NEMA Tests and Image Quality

Demir M., Abuqbeitah M., Yeyin N., Sonmezoglu K.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.32, sa.3, ss.95-99, 2017 (ESCI, Scopus, TRDizin)

47. RADYONÜKLİD TEDAVİLERDE DOZ HIZI ÖLÇÜMLERİ VE HASTA TABURCU EDİLME ZAMANININ DEĞERLENDİRİLMESİ THE EVALUATION OF DOSE RATE MEASUREMENTS AND DISCHARGE TIME AFTER RADIONUCLIDE THERAPY

YEYİN N., AKYEL R., Abuqubetah M., ÇAVDAR İ., SÖNMEZOĞLU K., DEMİR M.

İSTANBUL TIP FAKÜLTESİ DERGİSİ , cilt.80, sa.1, ss.1-6, 2017 (TRDizin)

48. A Retrospective Study for Total Effective Doses of Nuclear Medicine

Çavdar İ., Uslu Beşli L., Yeyin N., DEMİR M.

Journal of Nuclear Sciences , cilt.3, sa.2, ss.1-6, 2016 (TRDizin)

49. Evaluation of radiation safety in Lu-177-PSMA therapy and development of outpatient treatment protocol

DEMIR M., ABUQBEITAH M., Uslu-Beşli L., YıLDıRıM Ö., YEYIN N., CAVDAR I., et al.

JOURNAL OF RADIOLOGICAL PROTECTION , cilt.36, sa.2, ss.269-278, 2016 (SCI-Expanded, Scopus)

50. Radiation dose of caregivers could be reduced in thyroid carcinoma patients requiring high dose of radioactive iodine: A case report

Uslu-Besli L., Demir M., Yeyin N., Cavdar I.

IRANIAN JOURNAL OF NUCLEAR MEDICINE , cilt.24, sa.2, ss.144-146, 2016 (ESCI, Scopus)

51. Radiation dose of caregivers could be reduced in thyroid carcinoma patients requiring high dose of radioactive iodine: A case report

Uslu Beşli L., DEMİR M., Yeyin N., Çavdar İ.

Iran J Nucl Med , cilt.24, sa.2, ss.143-145, 2016 (Scopus)

52. Evaluation of radiation safety in 177Lu-PSMA therapy and development of outpatient treatment protocol

DEMİR M., ABUQBEITAH M., Uslu L., YıLDıRıM Ö., Yeyin N., Çavdar İ., et al.

JOURNAL OF RADIOLOGICAL PROTECTION , cilt.36, ss.269-278, 2016 (SCI-Expanded, Scopus)

53. Effects of hemodialysis on iodine-131 biokinetics in thyroid carcinoma patients with end-stage chronic renal failure

Yeyin N., Cavdar I., Uslu L., Abuqbeitah M., Demir M.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.37, sa.3, ss.283-287, 2016 (SCI-Expanded, Scopus)

54. A Retrospective Study for Total Effective Doses of Nuclear Medicine Employees in Istanbul, Turkey

ÇAVDAR İ., Uslu L., YEYİN N., DEMİR M.

Journal of Nuclear Sciences , cilt.3, ss.1-6, 2016 (Hakemli Dergi)

55. Pre-therapeutic dosimetry of normal organs and tissues of Lu-177-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer

Kabasakal L., AbuQbeitah M., Aygun A., Yeyin N., Ocak M., Demirci E., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.42, sa.13, ss.1976-1983, 2015 (SCI-Expanded, Scopus)

56. Determining and Managing Fetal Radiation Dose from Diagnostic Radiology Procedures in Turkey

Ozbayrak M., Cavdar I., Seven M., Uslu L., Yeyin N., Tanyildizi H., et al.

KOREAN JOURNAL OF RADIOLOGY , cilt.16, sa.6, ss.1276-1282, 2015 (SCI-Expanded, Scopus)

57. The evaluation of urine activity and external dose rate from patients receiving radioiodine therapy for thyroid cancer

Demir M., Parlak Y., Cavdar I., Yeyin N., Tanyildizi H., Gümüşer G., et al.

RADIATION PROTECTION DOSIMETRY , cilt.156, sa.1, ss.25-29, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

58. 177Lu-[DOTA0, Tyr3] octreotate therapy in iodine refractory thyroid cancer: Comparison of dosimetry with therapy of thyroid cancer and neuroendocrine tumors

Yeyin N., Toklu T., Demirci E., Kabasakal L., Aygun A., Ocak M., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.53, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

59. SURFACE CONTAMINATION RESEARCH ON RADIOIODINE TREATMENT SERVICE

Çavdar İ., Adıgüzel H., Yeyin N., DEMİR M.

BALKAN PHYSICS LETTERS , cilt.20, sa.201028, ss.243-248, 2012 (Hakemli Dergi)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 20

1. Biodistribution of Actinium-225 (Ac-225) and Bismuth-213 (Bi-213) in the kidney and liver in Ac-225 labeled PSMA and octreotate (DOTA TATE) treatment and the effect of 2,3-Dimercapto-1-propanesulfonic acid (DMPS) on biodistribution.

KARAYEL E., Pehlivanoglu H., Kibar A., YEYİN N., Onenerk A. M., KALAYCILAR İ. B., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 19 - 23 Ekim 2024, cilt.51, (Özet Bildiri)

2. Metastatik kastrasyona dirençli prostat kanserli hastalarda Lu-177 PSMA radioligand tedavisi, Cerrahpaşa deneyimi

Yeyin N.

31. Ulusal Nükleer Tıp Kongresi, Muğla, Türkiye, 10 - 14 Nisan 2019, ss.10, (Özet Bildiri) Sürdürülebilir Kalkınma

3. A new device (COTI) for thyroid uptake measurement and prospective dosimetry oriented therapy

Abuqbeitah M., DEMİR M., Yeyin N., Gray D., Sager S., Uslu-Besli L., et al.

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri)

4. Selective Internal Radiation Therapy (SIRT) for Liver Metastasis of Chemoresistant Breast Cancer: Overall Survival and Dose - Response Relationship

Akovali B., Akgun E. K., Şahin O. A., Yeyin N., Abuqbeitah M., Tanyildizi H., et al.

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri) Sürdürülebilir Kalkınma

5. The feasibility of relying on dose calculation for more successive therapy in Graves and Toxic adenoma guided by one year follow up

Abuqbeitah M., Sager S., Yeyin N., Uslu-Besli L., DEMİR M., Sonmezoglu K.

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, sa.1, (Özet Bildiri)

6. Determination of Radiation Dose in 177Lu-DOTATATE Treatment with 99m-Tc-HYNICTATE Scintigraphy

Yeyin N., Toklu T., Aygun A., Karayel E., Pehlivanoglu H., Demirci E., et al.

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, (Özet Bildiri)

7. Radiation exposurein 177Lu-PSMA and the possibly of applying outpatient treadment rules

Abuqbeitah M., DEMİR M., Yeyin N., Uslu-Beşli L., Vatankulu B., kabasakal l., et al.

European Association of Nuclear Medicine, 2016, Barselona, İspanya, 15 - 19 Ekim 2016, ss.201, (Tam Metin Bildiri)

8. Biodistribution patterns of Lu177-DKFZ-PSMA617 and Ga68-DKFZ-PSMA11 in the same patient group

Yeyin N., Sahin O. E., Vatankulu B., Toklu T., Demirci E., Aygun A., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine, Barcelona, İspanya, 15 - 19 Ekim 2016, cilt.43, (Özet Bildiri)

9. Radiation exposure in 177Lu-PSMA & the possibility of applying outpatient treatment rules

Abuqbeitah M., DEMİR M., Yeyin N., Uslu L., Vatankulu B., Kabasakal L., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, İspanya, 15 - 19 Ekim 2016, cilt.43, (Özet Bildiri)

10. Pre-therapy Bone Marrow And Lesion Absorbed Dose Estimation Using Different Dosimetry Models In Metastatic Differentiated Thyroid Cancer

Abuqbeitah M. M., Tanyildizi H., Cavdar I., Demir M., Yeyin N., Vatankulu B., et al.

28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 10 - 14 Ekim 2015, cilt.42, (Özet Bildiri) Sürdürülebilir Kalkınma

11. Dosimetry Results of Lu-177-DKFZ-PSMA-617 Treatment in Castration Resistant Prostate Cancer Patients

Yeyin N., Mohammad A., Kabasakal L., Demirci E., Aygun A., Ocak M., et al.

28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 10 - 14 Ekim 2015, cilt.42, (Özet Bildiri) Sürdürülebilir Kalkınma

12. Evaluation of in vivo and in vitro stability of Lu-177-DKFZ-617 for systemic radionuclide therapy in patients with castration resistant prostate cancer

Ocak M., Aygun A., Yeyin N., Demirci E., Karayel E., Araman A., et al.

28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 10 - 14 Ekim 2015, cilt.42, (Özet Bildiri) Sürdürülebilir Kalkınma

13. Differences in biodistribution of Lu-177-DKFZ-PSMA-617 and Ga-68-DKFZ-PSMA-11 in the same patient group

Sahin O. E., Nematyazar J., Razavi B., Yeyin N., Aygun A., Ocak M., et al.

28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 10 - 14 Ekim 2015, cilt.42, (Özet Bildiri)

14. Relationship of tumor absorbed doses of 177Lu-DOTA-TATE treatment and uptake in pre-therapeutic Ga68 DOTA-TATE PET/CT imaging

Demirci E., Kabasakal L., Yeyin N., Ocak M., Toklu T., Selcuk N., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Lyon, Fransa, 19 - 23 Ekim 2013, cilt.40, (Özet Bildiri)

15. Comparison of tumour and whole body absorbed doses of 177-Lu- DOTA-TATE and Lu-177 DOTA-NOC treatment in the same patient group

Yeyin N., Kabasakal L., Akyel R., Ocak M., Toklu T., Selcuk N., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Lyon, Fransa, 19 - 23 Ekim 2013, cilt.40, (Özet Bildiri)

16. Absorbed Dose Values After Radionuclide Therapy with LU-177 DOTA TATE in Patients with Neuroendocrine Tumor

Demir M., Yeyin N., Toklu T., Uslu L., Cavdar I., Kabasakal L.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Lyon, Fransa, 19 - 23 Ekim 2013, cilt.40, (Özet Bildiri)

17. Hepatobiliyer Sistem Sintigrafisinde Tc-99m Mebrofenin Kullanılarak Farklı Klirens Hesaplama Metodlarının Karşılaştırılması

Tanyıldızı H., KABASAKAL L., TUTAR R., Yılmaz S., Yeyin N., Aygün A., et al.

25.Ulusal Nükleer Tıp Kongresi, Antalya, Türkiye, 6 - 10 Nisan 2013, ss.96-97, (Tam Metin Bildiri)

18. Imaging of Metastatic-Recurrent Paragangliomas and Pheochromocytomas with Ga-68 DOTATATE PET/CT

Demirci E., Ocak M., Yeyin N., Asa S., Aygun A., Halac M., et al.

25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, İtalya, 27 - 31 Ekim 2012, cilt.39, (Özet Bildiri)

19. 177Lu-[DOTA0,Tyr3] octreotate therapy in iodine refractory thyroid cancer: Comparison of dosimetry with therapy of thyroid cancer and neuroendocrine tumors

Yeyin N., Demirci E., Toklu T., Kabasakal L., Aygun A., Ocak M., et al.

25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, İtalya, 27 - 31 Ekim 2012, cilt.39, (Özet Bildiri) Sürdürülebilir Kalkınma

20. Optimization of Physical Parameters and Quantification of Clinical Data in SPECT and PET/CT Imaging with Y-90

Demir M., Tanyildizi H., Yeyin N., Damgaci S., Uslu L., Aslan E., et al.

25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, İtalya, 27 - 31 Ekim 2012, cilt.39, (Özet Bildiri)

Kitaplar 4

Diğer Yayınlar 1

1. Lutesyum-177 İşaretli Terapötik Ajanlarda Dozimetrik Yaklaşım

Demir M., YEYİN N.

Diğer, ss.74-80, 2016

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

429

H-İndeks (WoS)

Atıf (Scopus)

471

H-İndeks (Scopus)

Atıf (Scholar)

112

H-İndeks (Scholar)

Toplam Atıf Sayısı

429

Proje

Fikri Mülkiyet

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Toplam Atıf Sayısı

Proje

Fikri Mülkiyet

Açık Erişim